UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                        Commission File Number: 000-33067

                             CUSIP Number: 70322H106

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING


(Check One): [ ] Form 10-K and Form 10-KSB    [ ] Form 20-F    [ ] Form 11-K

             [X] Form 10-Q and Form 10-QSB    [ ] Form N-SAR


  For Period Ended: SEPTEMBER 30, 2006

     [ ] Transition Report on Form 10-K      [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form 20-F      [ ] Transition Report on Form N-SAR
     [ ] Transition Report on Form 11-K

     For the Transition Period Ended :________________________

     Read attached  instruction  sheet before  preparing  form.  Please print or
type.

     Nothing in this form shall be  construed to imply that the  Commission  has
verified any information contained herein.

     If the  notification  related  to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:

       ------------------------------------------------------------------



                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant:   Patient Safety Technologies, Inc.
                           --------------------------------------------

Former name if applicable:
                           --------------------------------------------

Address of principal executive office (street and number):
                                               1800 Century Park East, Suite 200
                                               ---------------------------------

City, state and zip code:   Los Angeles, California  90067
                            ------------------------------


                                     PART II
                             RULE 12b-25 (b) and (c)

         If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate.)

[X]            (a)  The reasons described in reasonable detail in Part III of
                    this form could not be eliminated without unreasonable
                    effort or expense.

[X]            (b)  The subject annual report, semi-annual report, transition
                    report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion
                    thereof will be filed on or before the fifteenth calendar
                    day following the prescribed due date; or the subject
                    quarterly report or transition report on Form 10-Q or
                    portion thereof will be filed on or before the fifth
                    calendar day following the prescribed due date; and

               (c)  The accountant's statement or other exhibit required by Rule
                    12b-25(c)has been attached if applicable.


                                    PART III
                                    NARRATIVE

         State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q,  N-SAR or the transition  report portion thereof could not be filed within
the prescribed time period.

         The Company's  Quarterly Report on Form 10-QSB for the quarterly period
ended  September  30, 2006  cannot be filed  within the  prescribed  time period
because the  Company  requires  additional  time for  compilation  and review to
insure adequate disclosure of certain information required to be included in the
Form 10-QSB.  The Company's  Quarterly Report on Form 10-QSB will be filed on or
before the 5th calendar day following the prescribed due date.

                                       2


                                     PART IV
                                OTHER INFORMATION

         (1)   Name and telephone number of person to contact in regard to this
               notification:

               WILLIAM B. HORNE, CHIEF FINANCIAL OFFICER, (310) 895-7750

         (2)   Have all other periodic reports required under Section 13 or
               15(d) of the Securities Exchange Act of 1934 or Section 30 of the
               Investment Company Act of 1940 during the preceding 12 months or
               for such shorter period that the registrant was required to file
               such report(s) been filed? If the answer is no, identify
               report(s)

                                                    [X] Yes   [ ] No

         (3)   Is it anticipated that any significant change in results of
               operations from the corresponding period for the last fiscal year
               will be reflected by the earnings statements to be included in
               the subject report or portion thereof?

                                                    [X] Yes   [ ] No

               If so, attach an  explanation  of the  anticipated  change,  both
               narratively and  quantitatively,  and, if appropriate,  state the
               reason why a reasonable estimate of the results cannot be made.

               Patient Safety  Technologies,  Inc. (the  "COMPANY")  anticipates
               that its revenue for the three and nine  months  ended  September
               30, 2006 is significantly less than its revenue for the three and
               nine months ended  September 30, 2005. The decrease in revenue is
               primarily  the  result  of  a  decrease  in  consulting  services
               revenues   recognized  during  the  2006  periods.   The  Company
               anticipates  that  its  operating  expenses  and net loss for the
               three and nine months ended September 30, 2006 are  significantly
               greater  than the  expenses  and net loss for the  three and nine
               months  ended  September  30,  2005.  The  increase in  operating
               expenses for the three and nine months ended  September  30, 2006
               when compared to June 30, 2005, was primarily the result of stock
               based compensation expenses, amortization of debt discount and to
               a lesser  extent  salaries  and employee  benefits,  and interest
               expense.  Net loss  increased for the three and nine months ended
               September  30, 2006  compared to the three and nine months  ended
               September  30,  2005  primarily  as a  result  of  a  significant
               increase in operating expenses.

               A reasonable  estimate of the results cannot be made at this time
               due to the fact that the compilation, dissemination and review of
               the information required to be presented in the Form 10-Q has not
               been completed.

       ------------------------------------------------------------------

                                       3



                        PATIENT SAFETY TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
                  (Name of Registrant as specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date: November 15, 2006                     By:  /s/ WILLIAM B. HORNE
      ---------------------                      ----------------------------
                                            William B. Horne
                                            Chief Financial Officer



                                       4